PAG
SRRA

Private Advisor Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Private Advisor Group’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed -$1K – 3755
2020
Q2 		$1K Buy
+100
New +$1.24K ﹤0.01% 3801

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Private Advisor Group's SRRA Position: Q3 2020 in Review

Private Advisor Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2020, closing a stake of 100 shares — an estimated $1K sold.

Private Advisor Group first reported a position in SRRA in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 27 funds tracked by Wall St. Rank hold SRRA as of Q3 2020.

  • Private Advisor Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 100 Sierra Oncology, Inc. Common Stock shares in Q3 2020, an estimated $1K.
  • Private Advisor Group first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Sierra Oncology, Inc. Common Stock position peaked at $1K in Q2 2020.
  • 27 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.